NCT06004700

Brief Summary

The overall objective of this proposal is to test version 3.0 of the Arthritis smartphone app in a 12-month interrupted time series analysis (ITSA) design which will allow us to observe possible differences in visit frequency between the pre-and post-intervention periods as well as between the concurrent control group and those who receive the app. Our central hypothesis is that introduction of the app will reduce visit numbers per month in the group receiving the app, compared with a concurrent control group.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
278

participants targeted

Target at P75+ for not_applicable

Timeline
5mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2024Oct 2026

First Submitted

Initial submission to the registry

August 7, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 22, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

April 11, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

November 26, 2025

Status Verified

November 1, 2025

Enrollment Period

2.5 years

First QC Date

August 7, 2023

Last Update Submit

November 21, 2025

Conditions

Keywords

ArthritisPsoriatic ArthritisMobile Health

Outcome Measures

Primary Outcomes (1)

  • Visit Frequency

    The differences in visit frequency, between the pre-and post-intervention periods and between the concurrent control group and those who receive the app

    12 Months

Secondary Outcomes (6)

  • Patient Reported Outcomes Measurement Information System (PROMIS) Function short form

    12 Months

  • Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue short form

    12 Months

  • Patient Reported Outcomes Measurement Information System (PROMIS) Pain short form

    12 Months

  • Psoriatic Arthritis Impact of Disease 12-item questionnaire (PsAID-12) for Clinical Practice

    12 Months

  • Standardized questionnaires for Arthritis Disease Activity

    12 Months

  • +1 more secondary outcomes

Study Arms (2)

Mobile Application

EXPERIMENTAL

This arm of the study will contain half the study population after randomization. The participants in this arm will receive the EHR integrated app and follow a 12-month interrupted time series analysis (ITSA) design. n = 260

Other: Mobile Application

Controls

NO INTERVENTION

This arm of the study will contain half the study population after randomization. The participants in this arm will be from the same rheumatologists as the experimental participants and will be used as concurrent controls by accessing their data on visits from the EHR during the same time period. n = 260

Interventions

The current app contains a disease activity questionnaire, a mood scale, a sleep scale, a pain scale, and a functional status scale. The app triggers a brief set of questions each day and allows patients to answer them within 24 hours.

Mobile Application

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be diagnosed with PsA by a board-certified rheumatologist and been seen at least twice in the prior year
  • Own a smartphone with either an Android or iPhone operating system
  • Be at least 18 years old
  • Be English-speaking
  • Using guselkumab, infliximab, golimumab or ustekinumab

You may not qualify if:

  • Patients who do not plan on receiving follow-up care at the Brigham and Women's Arthritis Center will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Related Publications (4)

  • Battafarano DF, Ditmyer M, Bolster MB, Fitzgerald JD, Deal C, Bass AR, Molina R, Erickson AR, Hausmann JS, Klein-Gitelman M, Imundo LF, Smith BJ, Jones K, Greene K, Monrad SU. 2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015-2030. Arthritis Care Res (Hoboken). 2018 Apr;70(4):617-626. doi: 10.1002/acr.23518.

    PMID: 29400009BACKGROUND
  • Rose M, Bjorner JB, Becker J, Fries JF, Ware JE. Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2008 Jan;61(1):17-33. doi: 10.1016/j.jclinepi.2006.06.025.

    PMID: 18083459BACKGROUND
  • Lai JS, Cella D, Choi S, Junghaenel DU, Christodoulou C, Gershon R, Stone A. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil. 2011 Oct;92(10 Suppl):S20-7. doi: 10.1016/j.apmr.2010.08.033.

    PMID: 21958919BACKGROUND
  • Amtmann D, Cook KF, Jensen MP, Chen WH, Choi S, Revicki D, Cella D, Rothrock N, Keefe F, Callahan L, Lai JS. Development of a PROMIS item bank to measure pain interference. Pain. 2010 Jul;150(1):173-182. doi: 10.1016/j.pain.2010.04.025.

    PMID: 20554116BACKGROUND

MeSH Terms

Conditions

ArthritisArthritis, Psoriatic

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesPsoriasisSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
A matched control group will be enrolled from medical records. The data analyst will be blinded to the treatment assignment (i.e., app intervention or matched controls)
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

August 7, 2023

First Posted

August 22, 2023

Study Start

April 11, 2024

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

November 26, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations